SynCell: Contextualized Drug Synergy Prediction

Fuente: arXiv
Enregistré dans:
Détails bibliographiques
Auteurs principaux: Peng, Keqin, Su, Guangxin, Shi, Qinshan, Gao, Shuai, Wang, Ren, Chen, Can, Wen, Jun
Format: Preprint
Publié: 2025
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1866914414084489216
author Peng, Keqin
Su, Guangxin
Shi, Qinshan
Gao, Shuai
Wang, Ren
Chen, Can
Wen, Jun
author_facet Peng, Keqin
Su, Guangxin
Shi, Qinshan
Gao, Shuai
Wang, Ren
Chen, Can
Wen, Jun
contents Drug synergy is profoundly influenced by cellular context, as variations in protein interaction landscapes and pathway activities across cell types reshape how drugs act in combination. Most existing models overlook this heterogeneity, relying on static or bulk-level protein-protein interaction (PPI) networks that ignore cell-specific molecular wiring. The availability of large-scale transcriptomic data now enables the reconstruction of cell-line-resolved interactomes, offering a new foundation for contextualized drug synergy modeling. Here we present SynCell, a Contextualized Drug Synergy framework that integrates drug-protein, protein-protein, and protein-cell line relations within a unified graph architecture. SynCell leverages cell-line-specific PPI networks to embed the molecular context in which drugs act, and employs graph convolutional learning to model how pharmacological effects propagate through cell-specific signaling networks. This formulation treats synergy prediction as a cell-line-contextualized drug-drug interaction problem. Across the large-scale DrugCombDB benchmark, SynCell consistently outperforms state-of-the-art baselines - including DeepSynergy, HypergraphSynergy, HERMES, BAITSAO, DTF, and NHP - particularly in predicting synergies involving unseen drugs or novel cell lines. When benchmarked against these seven methods, SynCell demonstrates substantial gains in generalization and biological interpretability, confirming that contextualizing PPIs with cell-line resolution is indispensable for accurate synergy prediction.
format Preprint
id arxiv_https___arxiv_org_abs_2511_17695
institution arXiv
publishDate 2025
record_format arxiv
spellingShingle SynCell: Contextualized Drug Synergy Prediction
Peng, Keqin
Su, Guangxin
Shi, Qinshan
Gao, Shuai
Wang, Ren
Chen, Can
Wen, Jun
Quantitative Methods
Drug synergy is profoundly influenced by cellular context, as variations in protein interaction landscapes and pathway activities across cell types reshape how drugs act in combination. Most existing models overlook this heterogeneity, relying on static or bulk-level protein-protein interaction (PPI) networks that ignore cell-specific molecular wiring. The availability of large-scale transcriptomic data now enables the reconstruction of cell-line-resolved interactomes, offering a new foundation for contextualized drug synergy modeling. Here we present SynCell, a Contextualized Drug Synergy framework that integrates drug-protein, protein-protein, and protein-cell line relations within a unified graph architecture. SynCell leverages cell-line-specific PPI networks to embed the molecular context in which drugs act, and employs graph convolutional learning to model how pharmacological effects propagate through cell-specific signaling networks. This formulation treats synergy prediction as a cell-line-contextualized drug-drug interaction problem. Across the large-scale DrugCombDB benchmark, SynCell consistently outperforms state-of-the-art baselines - including DeepSynergy, HypergraphSynergy, HERMES, BAITSAO, DTF, and NHP - particularly in predicting synergies involving unseen drugs or novel cell lines. When benchmarked against these seven methods, SynCell demonstrates substantial gains in generalization and biological interpretability, confirming that contextualizing PPIs with cell-line resolution is indispensable for accurate synergy prediction.
title SynCell: Contextualized Drug Synergy Prediction
topic Quantitative Methods
url https://arxiv.org/abs/2511.17695